Levoleucovorin
Colonic Neoplasm
Asan Medical CenterPhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 81/ 100
Competitive context
14 Active assets in the Colonic Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin First Affiliated Hospital of Guangxi Medical University | Phase 4 | BBB |
PROPOFOL Hillel Yaffe Medical Center | Phase 4 | BB |
Ertapenem University of Ulm | Phase 4 | BB |
Sevoflurane Uppsala University | Phase 4 | BB |
Capecitabine First Affiliated Hospital of Guangxi Medical University | Phase 3 | B |
View all 50 →
Same molecule, other indications
Levoleucovorin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →